Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

Share Price is delayed by 15 minutes
Get Live Data
499.40    -0.60 (-0.12%)
Bid:
500.00
Ask:
501.00
Spread: 1.00 (0.20%)
Market Cap: £1.35b
CHG Live PriceLast checked at - London Stock Exchange

Intraday Chemring Share Chart

Director/PDMR Shareholding

3 Oct 2023 14:28

RNS Number : 5627O
Chemring Group PLC
03 October 2023
 

3 October 2023

 

Chemring Group PLC

 

Exercise of sharesave options

 

 

Chemring Group PLC ("Chemring" or "the Company") announces that on 3 October 2023 Andrew Lewis, Sarah Ellard and Michael Ord directors of the Company, exercised options granted under the Chemring Group 2018 UK Sharesave Plan on 30 July 2020 and the Chemring Group 2018 UK Sharesave Plan on 30 July 2018, respectively, as detailed below.

 

The following table details the transactions which were notified to the Company:

 

Director

Options exercised

Sharesave Plan

Resultant beneficial interest in the Company's shares

Andrew Lewis

8,910

Chemring Group 2018 UK Sharesave Plan granted on 30 July 2020

315,717

Sarah Ellard

8,910

Chemring Group 2018 UK Sharesave Plan granted on 30 July 2020

246,243

Michael Ord

16,853

Chemring Group 2018 UK Sharesave Plan granted on 30 July 2018

576,906

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

 Andrew Lewis

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director/PDMR

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Chemring Group PLC

b)

 

LEI

 

 

213800U9A54VQJ5P2J41

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

1p ordinary shares

 

 

 

GB00B45C9X44

b)

 

Nature of the transaction

 

 

Exercise of options granted 30 July 2020

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

202p exercise price

 

8,910

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

N/A

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

3 October 2023

f)

 

Place of the transaction

 

 

UK

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

 Sarah Ellard

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director/PDMR

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Chemring Group PLC

b)

 

LEI

 

 

213800U9A54VQJ5P2J41

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

1p ordinary shares

 

 

 

GB00B45C9X44

b)

 

Nature of the transaction

 

 

 Exercise of options granted on 30 July 2020

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

202p exercise price

 

8,910

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

N/A

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

3 October 2023

f)

 

Place of the transaction

 

 

UK

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

 Michael Ord

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director/PDMR

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Chemring Group PLC

b)

 

LEI

 

 

213800U9A54VQJ5P2J41

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

1p ordinary shares

 

 

 

GB00B45C9X44

b)

 

Nature of the transaction

 

 

 Exercise of options granted 30 July 2018

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

178p exercise price

 

16,853

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

N/A

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

3 October 2023

f)

 

Place of the transaction

 

 

UK

 

For further information:

Chemring Group PLC

Sarah Ellard

Group Legal Director

+44 (0)1794 463420

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFFVISLVIIV
Date   Source Headline
2nd Dec 20247:00 amRNSTotal Voting Rights
14th Nov 20247:19 amRNSDirector Declaration
6th Nov 20247:15 amRNSDirector Declaration
4th Nov 20247:00 amRNS£278m Contract Wins
1st Nov 20247:00 amRNSTransaction in Own Shares
1st Nov 20247:00 amRNSTotal Voting Rights
31st Oct 20247:00 amRNSTransaction in Own Shares
17th Oct 20247:00 amRNSTrading Update
14th Oct 202412:29 pmRNSHolding(s) in Company
1st Oct 20247:00 amRNSTotal Voting Rights
2nd Sep 20247:00 amRNSTotal Voting Rights
16th Aug 202410:10 amRNSAdditional Listing
5th Aug 202410:03 amRNSDirector/PDMR Shareholding
1st Aug 20247:00 amRNSTotal Voting Rights
18th Jul 20242:34 pmRNSDirector Declaration
1st Jul 20247:00 amRNSTotal Voting Rights
24th Jun 20247:00 amRNSAppointment of Chairman-designate
19th Jun 20247:00 amRNSBlock listing update
18th Jun 20247:00 amRNSBlock listing Interim Review
10th Jun 20247:00 amRNSContract Award
4th Jun 20247:00 amRNSHalf-year Report
3rd Jun 20247:00 amRNSTotal Voting Rights
1st May 202411:29 amRNSTotal Voting Rights
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20249:13 amRNSTotal Voting Rights
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSDirector/PDMR Shareholding
25th Mar 20247:00 amRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSFunding Awards
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:00 amRNSTotal Voting Rights
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 202412:45 pmRNSResult of AGM
23rd Feb 20247:00 amRNSAGM Update
16th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.